Emerging in the field of weight management treatment, retatrutide is a different method. Unlike many available medications, retatrutide functions as a double agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) sensors. This simultaneous stimulation promotes various beneficial effects, i